We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.9B
AUM Growth
-$1.1B
(-1.2%)
Cap. Flow
-$993M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
13.47%
Holding
1,034
New
126
Increased
424
Reduced
317
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$359M |
| 2 |
Melco Resorts & Entertainment
MLCO
|
+$271M |
| 3 |
HCA Healthcare
HCA
|
+$231M |
| 4 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$198M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$535M |
| 2 |
EPB
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
|
+$487M |
| 3 |
AGN
Allergan Inc
AGN
|
+$289M |
| 4 |
Mercado Libre
MELI
|
+$281M |
| 5 |
Pfizer
PFE
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 18.68% |
| 2 | Financials | 13.84% |
| 3 | Communication Services | 12.14% |
| 4 | Healthcare | 11.85% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Puma Biotechnology
PBYI
$406M
| $10.2M | 0.01% |
53,780
-820
| -2% | -$182K |
|
752
Protolabs
PRLB
$1.86B
| $10.1M | 0.01% |
150,059
-390,700
| -72% | -$25.7M |
|
753
WisdomTree India Earnings Fund ETF
EPI
$2.02B
| $10.1M | 0.01% |
456,870
+35,800
| +9% | +$804K |
|
754
State Street
STT
$50.9B
| $10M | 0.01% |
+127,880
| New | +$9.6M |
|
755
Nu Skin
NUS
$247M
| $10M | 0.01% |
+229,336
| New | +$10.1M |
|
756
DTE Energy
DTE
$31.1B
| $10M | 0.01% |
136,100
+5,311
| +4% | +$369K |
|
|
ANDV
757
DELISTED
Andeavor
ANDV
| $9.89M | 0.01% |
133,000
-7,060
| -5% | -$498K |
|
|
SFUN
758
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $9.87M | 0.01% |
26,715
+2,135
| +9% | +$941K |
|
759
Alliant Energy
LNT
$19.4B
| $9.79M | 0.01% |
294,800
+11,520
| +4% | +$357K |
|
760
HealthEquity
HQY
$7.91B
| $9.79M | 0.01% |
384,540
+30,140
| +9% | +$654K |
|
|
RKT
761
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $9.72M | 0.01% |
159,470
-7,770
| -5% | -$421K |
|
762
Halozyme
HALO
$9.72B
| $9.65M | 0.01% |
1,000,000
| – | – |
|
|
CST
763
DELISTED
CST Brands, Inc.
CST
| $9.65M | 0.01% |
221,225
-23,950
| -10% | -$962K |
|
764
National CineMedia
NCMI
$354M
| $9.61M | 0.01% |
66,879
+1,015
| +2% | +$146K |
|
765
Plains GP Holdings
PAGP
$5.23B
| $9.58M | 0.01% |
140,087
+52,967
| +61% | +$3.76M |
|
766
IPG Photonics
IPGP
$3.89B
| $9.49M | 0.01% |
+126,665
| New | +$9.01M |
|
767
Affiliated Managers Group
AMG
$9.46B
| $9.49M | 0.01% |
44,710
-34,120
| -43% | -$6.78M |
|
|
PETX
768
DELISTED
Aratana Therapeutics, Inc.
PETX
| $9.46M | 0.01% |
530,652
+73,433
| +16% | +$915K |
|
|
NTK
769
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $9.45M | 0.01% |
116,241
| – | – |
|
770
Gartner
IT
$9.41B
| $9.29M | 0.01% |
+110,370
| New | +$8.97M |
|
771
Old Republic International
ORI
$10.3B
| $9.24M | 0.01% |
+631,723
| New | +$9.23M |
|
772
Brookdale Senior Living
BKD
$3.62B
| $9.18M | 0.01% |
250,380
-21,140
| -8% | -$717K |
|
773
Jazz Pharmaceuticals
JAZZ
$15.9B
| $9.15M | 0.01% |
+55,870
| New | +$9.27M |
|
|
USDP
774
DELISTED
USD PARTNERS LP
USDP
| $9.11M | 0.01% |
+642,810
| New | +$9.83M |
|
775
EQT Corp
EQT
$33.2B
| $9.09M | 0.01% |
220,587
+2,774
| +1% | +$131K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2014 Portfolio in Review
As of Q4 2014, OppenheimerFunds held 1,034 positions worth $89.9B, down 1.2% from $91B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q4 2014 filing shows 126 new, 424 increased, 317 reduced and 112 closed positions. Its largest new stake was Melco Resorts & Entertainment: 10,809,650 shares worth $275M. The largest sale was Baidu, an estimated $535M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.
- OppenheimerFunds's largest Q4 2014 buy was Melco Resorts & Entertainment: 10,809,650 shares worth $275M.
- OppenheimerFunds added most to JD.com in Q4 2014, an estimated $359M increase.
- OppenheimerFunds's biggest Q4 2014 reduction was Baidu, cutting an estimated $535M.
- OppenheimerFunds fully exited EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART in Q4 2014, selling an estimated $487M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.9B portfolio in Q4 2014.
- OppenheimerFunds opened 126 new positions and closed 112 in Q4 2014.
- OppenheimerFunds's portfolio value fell 1.2% quarter-over-quarter to $89.9B.
Based on OppenheimerFunds's 13F filing for Q4 2014, filed 11 Feb 2015.